(NASDAQ: RPID) Rapid Micro Biosystems's forecast annual revenue growth rate of 22.83% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.42%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.8%.
Rapid Micro Biosystems's revenue in 2026 is $34,384,000.On average, 6 Wall Street analysts forecast RPID's revenue for 2026 to be $1,842,889,867, with the lowest RPID revenue forecast at $1,741,963,991, and the highest RPID revenue forecast at $1,914,867,653. On average, 6 Wall Street analysts forecast RPID's revenue for 2027 to be $2,193,360,279, with the lowest RPID revenue forecast at $1,990,815,990, and the highest RPID revenue forecast at $2,375,405,443.
In 2028, RPID is forecast to generate $3,061,018,093 in revenue, with the lowest revenue forecast at $2,940,978,167 and the highest revenue forecast at $3,151,048,037.